Kemp Jens bought AXGN
February 26, 2026 · Form 4 insider transaction
Kemp Jens bought 50,670 shares of Axogen, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,670
Price
$0.00
Total value
N/A
InsiderKemp Jens
Role—
CompanyAxogen, Inc. (AXGN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateMarch 2, 2026
Shares owned after94,817
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This reflects the number of shares that became vested as of February 26, 2026, upon the attainment and certification of certain performance criteria.; The previous Form 4 filed by the Reporting Person overstated the number of shares beneficially owned by the Reporting Person by 4,003 shares of Common Stock. The amount reported herein has been corrected.; Includes 2,120 shares acquired under the Axogen Employee Stock Purchase Plan on December 31, 2025.